Olink Holding AB (publ) (OLK)
NASDAQ: OLK · IEX Real-Time Price · USD
23.02
+0.34 (1.50%)
May 2, 2024, 4:30 PM EDT - Market closed
Olink Holding AB (publ) Revenue
In the year 2023, Olink Holding AB (publ) had annual revenue of $169.60M with 21.27% growth. Revenue in the quarter ending December 31, 2023 was $68.55M with 18.43% year-over-year growth.
Revenue (ttm)
$169.60M
Revenue Growth
+21.27%
P/S Ratio
16.88
Revenue / Employee
$239,883
Employees
707
Market Cap
2.86B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 169.60M | 29.75M | 21.27% |
Dec 31, 2022 | 139.85M | 44.88M | 47.25% |
Dec 31, 2021 | 94.97M | 40.91M | 75.66% |
Dec 31, 2020 | 54.07M | 12.37M | 29.68% |
Dec 31, 2019 | 41.69M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amedisys | 2.25B |
GoodRx Holdings | 750.27M |
ACADIA Pharmaceuticals | 726.44M |
Azenta | 641.02M |
Certara | 354.34M |
Immunocore Holdings | 249.43M |
Arrowhead Pharmaceuticals | 181.74M |
Arcellx | 110.32M |
OLK News
- 13 days ago - Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 - GlobeNewsWire
- 5 weeks ago - Olink reports fourth quarter and full year 2023 financial results - GlobeNewsWire
- 6 weeks ago - Notice to attend the Annual General Meeting of Olink Holding AB (publ) - GlobeNewsWire
- 7 weeks ago - Olink announces change of date for Annual General Meeting - GlobeNewsWire
- 6 months ago - Olink reports third quarter 2023 financial results - GlobeNewsWire
- 6 months ago - Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics - GlobeNewsWire
- 6 months ago - OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK - Business Wire
- 6 months ago - Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink - Business Wire